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Therapeutic use exemptions – serving 
athlete patients
To the Editor: As members of the Therapeutic Use Exemption 
Committee (TUEC) of the South African Institute for Drug-Free 
Sport (SAIDS), we thank colleagues throughout the country for 
supporting athletes in their applications for a therapeutic use 
exemption (TUE). It is our intention to shed light on what might at 
times appear a cumbersome and inscrutable process for those not 
involved in anti-doping.
The management of athlete patients obligated to the World 
Anti-Doping Code (WADC)[1] presents some unique challenges 
for physicians. Whenever such management requires the use of 
substances that are on the annually updated World Anti-Doping 
Agency (WADA) Prohibited List,[2] South African (SA) athletes have 
to apply for a TUE to the SAIDS. A TUE allows an athlete to use a 
prohibited substance at a specified dosage and frequency for a limited 
amount of time. 
The SAIDS is a signatory to the WADC and has to follow 
all of its provisions.[3] With regard to TUEs, these provisions 
ensure  an unequivocal entitlement to appropriate medical care 
while monitoring the possibility that prohibited substances could be 
misused for performance enhancement. 
The WADC obliges the SAIDS to define and publish the process 
by which athletes may apply for a TUE and to establish a TUEC 
consisting of at least three physicians with experience in the field. The 
TUEC itself has to meet the requirements of the WADA International 
Standard for Therapeutic Use Exemptions[4] in all its various aspects. 
We regard athletes subjected to the WADC as no different to other 
patients in occupations that demand a unique approach to their 
clinical management (e.g. airline pilots, professional scuba divers). 
By accepting the clinical care of an athlete patient, the physician 
also becomes bound by the WADC, which entails a number of 
professional obligations such as providing a complete medical file to 
support a TUE application.
When considering a TUE application, the TUEC looks for answers 
to the following questions:
• Has evidence of appropriate investigations been provided to 
support the clinical diagnosis?
• Has this been endorsed by an appropriate medical specialist?
• Would denial of this  application jeopardise the health of the 
patient?
• Are there non-prohibited, alternative medications that could have 
been used instead?
• If so, is there supportive evidence that their use was ineffective?
• Could this clinical condition be the result of the prior use of a 
prohibited substance?
It is of crucial importance to understand that the requirements for the 
medical file supporting a TUE application are not at the discretion of 
the SAIDS TUEC, but follow defined international standards.[5] The 
sole purpose of any TUE application review is to establish whether 
these standards are met; it must never be perceived as questioning a 
colleague’s expertise or patient management. 
The ultimate goal of the TUE system is to create a level playing 
field for athlete patients worldwide. If SAIDS’s TUEs do not meet 
international standards, SA athletes may not be able to compete 
at world elite level because their TUEs will not be recognised by 
international sports bodies.
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